AI drug discovery funding heats up again as speed promises move toward the clinical evidence test
More than $2 billion in funding has flowed in, shifting AI drug discovery from an algorithm narrative to a bet on R&D efficiency; but claims of shortened timelines still must undergo layered scrutiny through human trials and regulatory data.